KIRKMAN ROBERT L 4
4 · Oncothyreon Inc. · Filed Dec 14, 2012
Insider Transaction Report
Form 4
Oncothyreon Inc.ONTY
KIRKMAN ROBERT L
DirectorPresident/CEO
Transactions
- Award
Stock Option (right to buy)
2012-12-12+100,000→ 100,000 totalExercise: $4.74Exp: 2020-12-12→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]The option vests and is exercisable at the rate of 1/4th of the total shares on December 12, 2013 and then 1/48th of the total shares vest and are exercisable monthly thereafter, with 100% vested and exercisable on December 12, 2016.